Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
Moving towards the pan-European unification of Multiple Sclerosis Nurses: a consensus paper.
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.
Narcolepsy with cataplexy and comorbid immunopathological diseases.
Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
Pharmaceutical approval update.
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
Associations of CD6, TNFRSF1A, and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.
A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica).
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
UW-SES: A new self-efficacy scale for people with disabilities.
Multiple Sclerosis: Vitamin D and calcium as environmental determinants of prevalence (A Viewpoint)
CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
Progressive Multifocal Leukoencephalopathy
Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients.
Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report.
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
Vivitrol dosing and administration
A phase II study of laquinimod in Crohn's disease.
Apitope Announces Completion of Enrolment in Phase IIA Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells.

Pages